Trademarkia Logo

Australia

AU$
KENLIFABI
Protected: Registered/protected

Last updated on 18 May 2022

Owner Info

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91

CH-4123 Allschwil, SWITZERLAND

Serial Number

2254898 filed on 10 Jan 2022

Correspondent

Keller Schneider Patent- und Markenanwälte AG

Beethovenstrasse 49,,

P.O. Box,

SWITZERLAND

KENLIFABI

Classification Information


Class [005]
Pharmaceutical preparations for human use for the treatment of Fabry disease and the symptoms and sequelae of Fabry disease, as well as for the treatm Read More

Mark Details


Serial Number

2254898

Registered On

10 Jan 2022

Renewal On

10 Jan 2032

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 Jul 2021

Mark Type

CH

Legal History


Show more

Status DateAction Taken
18th May 2022International Registration in Australia Protected correspondence sent
17th May 2022IP Right Registration Published
17th May 2022Status change to Registered/Protected
11th Mar 2022Application Accepted correspondence sent
10th Mar 2022IP Right has been Examined
10th Mar 2022IP Right Acceptance Published
10th Mar 2022Status change to Accepted
10th Mar 2022Awaiting examination
10th Mar 2022Examination expedited
10th Mar 2022IP Right Filed Published